Vimarsana
Biggest News Aggregation in the World

Page 28 - Thomas Meyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Meyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Meyer Today - Breaking & Trending Today

Altamira Therapeutics Receives Approval to Commence Clinical Trial Evaluating Bentrio in the Treatment of COVID-19 - Vimarsana News

Altamira Therapeutics Receives Approval to Commence Clinical Trial Evaluating Bentrio in the Treatment of COVID-19

09.03.2022 - HAMILTON, BERMUDA / ACCESSWIRE / March 9, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced that its affiliate, Altamira Medica, has received ... Seite 1

Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets - Vimarsana News

Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets

Press release content from Accesswire. The AP news staff was not involved in its creation.

Source: apnews.com
Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets - Vimarsana News

Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets

Nuance Pharma to develop and commercialize Bentrio nasal spray in Chinese Mainland, Hong Kong, Macau and South KoreaAltamira to receive up to $23.5 million in upfront and milestone payments during initial

Short Interest in Altamira Therapeutics Ltd (NASDAQ:CYTO) Decreases By 66.4% - Vimarsana News

Short Interest in Altamira Therapeutics Ltd (NASDAQ:CYTO) Decreases By 66.4%

Altamira Therapeutics Ltd (NASDAQ:CYTO – Get Rating) saw a significant drop in short interest in February. As of February 15th, there was short interest totalling 57,900 shares, a drop of 66.4% from the January 31st total of 172,200 shares. Approximately 0.9% of the shares of the stock are sold short. Based on an average daily […]

Altamira Therapeutics and Wellesta Expand Bentrio Marketing and Distribution Agreement to Include Two Additional Markets - Vimarsana News

Altamira Therapeutics and Wellesta Expand Bentrio Marketing and Distribution Agreement to Include Two Additional Markets

Press release content from Accesswire. The AP news staff was not involved in its creation.

Source: apnews.com